We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
1101
PUT
Palo Alto Networks
PANW
$261B
$8K ﹤0.01%
+1,140
New +$91.5K
SUPN icon
1102
Supernus Pharmaceuticals
SUPN
$2.71B
$8K ﹤0.01%
217
+35
+19% +$1.22K
ARVN icon
1103
Arvinas
ARVN
$534M
$7K ﹤0.01%
198
GMAB icon
1104
Genmab
GMAB
$17.7B
$7K ﹤0.01%
172
+35
+26% +$1.44K
IRWD icon
1105
Ironwood Pharmaceuticals
IRWD
$604M
$7K ﹤0.01%
573
MRVI icon
1106
Maravai LifeSciences
MRVI
$984M
$7K ﹤0.01%
490
PACB icon
1107
Pacific Biosciences
PACB
$450M
$7K ﹤0.01%
909
+227
+33% +$1.96K
PCRX icon
1108
Pacira BioSciences
PCRX
$1.04B
$7K ﹤0.01%
169
RLAY icon
1109
Relay Therapeutics
RLAY
$4.1B
$7K ﹤0.01%
486
+81
+20% +$1.55K
RYTM icon
1110
Rhythm Pharmaceuticals
RYTM
$7.41B
$7K ﹤0.01%
227
+55
+32% +$1.41K
SWTX
1111
DELISTED
SpringWorks Therapeutics
SWTX
$7K ﹤0.01%
251
+67
+36% +$1.65K
VTYX
1112
DELISTED
Ventyx Biosciences
VTYX
$7K ﹤0.01%
+228
New +$6.75K
AGIO icon
1113
Agios Pharmaceuticals
AGIO
$2.11B
$6K ﹤0.01%
204
DAWN
1114
DELISTED
Day One Biopharmaceuticals
DAWN
$6K ﹤0.01%
296
+115
+64% +$2.36K
KYNB
1115
Kyntra Bio
KYNB
$27.9M
$6K ﹤0.01%
15
+2
+15% +$766
IMCR icon
1116
Immunocore
IMCR
$1.7B
$6K ﹤0.01%
+104
New +$5.85K
KYMR icon
1117
Kymera Therapeutics
KYMR
$8.84B
$6K ﹤0.01%
221
+71
+47% +$1.89K
MNKD icon
1118
MannKind Corp
MNKD
$1.21B
$6K ﹤0.01%
1,058
+203
+24% +$831
NUVL
1119
DELISTED
Nuvalent
NUVL
$6K ﹤0.01%
205
+80
+64% +$2.23K
RCKT icon
1120
Rocket Pharmaceuticals
RCKT
$342M
$6K ﹤0.01%
304
+86
+39% +$1.58K
SNDX icon
1121
Syndax Pharmaceuticals
SNDX
$1.74B
$6K ﹤0.01%
242
+75
+45% +$1.75K
VCYT icon
1122
Veracyte
VCYT
$4.51B
$6K ﹤0.01%
266
VRNA
1123
DELISTED
Verona Pharma
VRNA
$6K ﹤0.01%
+244
New +$3.25K
XNCR icon
1124
Xencor
XNCR
$1.47B
$6K ﹤0.01%
222
RVNC
1125
DELISTED
Revance Therapeutics, Inc.
RVNC
$6K ﹤0.01%
331
+85
+35% +$1.94K

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.